New pages
- 21:06, 20 April 2021 Chronic myelogenous leukemia, pediatric (hist) [5,662 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 22:05, 19 April 2021 Acute myeloid leukemia, pediatric (hist) [31,082 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 21:29, 19 April 2021 B-cell acute lymphoblastic leukemia, Ph-positive, pediatric (hist) [9,934 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 20:50, 19 April 2021 Hodgkin lymphoma, pediatric (hist) [27,137 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 21:00, 18 April 2021 T-cell acute lymphoblastic leukemia, pediatric (hist) [38,967 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 22:11, 17 April 2021 B-cell acute lymphoblastic leukemia, pediatric (hist) [76,613 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 13:12, 8 April 2021 Sutimlimab (BIVV009) (hist) [594 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Anti-C1s antibody ==Preliminary data== #'''CARDINAL:''' Röth A, Barcellini W, D'Sa S, Miyakawa Y, Broome CM, Michel M, Kuter DJ, Jilma B, Tvedt THA,...")
- 20:34, 30 March 2021 Voxelotor (Oxbryta) (hist) [526 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== hemoglobin S polymerization inhibitor ==Diseases for which it is used== *Sickle cell anemia ==History of changes in FDA indication== *11/25/2019:...")
- 13:45, 25 March 2021 Beta thalassemia (hist) [2,893 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#31a354"|'''Section editor''' |- |s...")
- 11:30, 17 March 2021 Esophageal squamous cell carcinoma (hist) [31,383 bytes] Ryannguyen (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Page editor''' ! col...")
- 18:47, 11 March 2021 Esophageal adenocarcinoma (hist) [114,356 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Page editor''' ! col...")
- 21:37, 8 March 2021 Bladder cancer - historical (hist) [7,236 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 18:14, 5 March 2021 Pirtobrutinib (LOXO-305) (hist) [1,040 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-loxo-305 NCI Drug Dictionary]: An orally available, selective,...")
- 12:50, 3 March 2021 Melphalan flufenamide (Pepaxto) (hist) [1,835 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide NCI Drug Dictionary]: A peptide-drug conjugate compose...")
- 11:05, 3 March 2021 Waldenström macroglobulinemia - historical (hist) [7,352 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 15:18, 21 February 2021 Sarcomatoid renal cell carcinoma (hist) [4,225 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |...")
- 14:59, 21 February 2021 Papillary renal cell carcinoma (hist) [9,318 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |...")
- 22:08, 19 February 2021 Low-grade serous ovarian cancer (hist) [7,303 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable sortable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor...")
- 19:18, 8 February 2021 Linsitinib (OSI-906) (hist) [1,236 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitini...")
- 13:58, 8 February 2021 Sintilimab (IBI 308) (hist) [1,716 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sintilimab NCI Drug Dictionary]: A recombinant human monoclonal antibody directe...")
- 12:21, 8 February 2021 Brexucabtagene autoleucel (Tecartus) (hist) [2,235 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel NCI Drug Dictionary]: A preparation of autologous...")
- 13:28, 23 January 2021 Flumatinib (HH-GV-678) (hist) [1,583 bytes] Jwarner (talk | contribs) (Created page with "==General information== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate NCI Drug Dictionary]: The orally bioavailable, mesylate...")
- 09:46, 22 January 2021 Adavosertib (MK-1775) (hist) [1,825 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib NCI Drug Dictionary]: A small molecule inhibitor of the tyrosine...")
